alendronate has been researched along with Leanness in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In conclusion, thinness is an important risk factor for low bone mass and increased bone loss in postmenopausal women." | 2.69 | Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. ( Bjarnason, NH; Christiansen, C; Cizza, G; Daley, M; Hosking, D; McClung, M; Ravn, P; Thompson, D; Wasnich, RD; Yates, AJ, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ravn, P | 1 |
| Cizza, G | 1 |
| Bjarnason, NH | 1 |
| Thompson, D | 1 |
| Daley, M | 1 |
| Wasnich, RD | 1 |
| McClung, M | 1 |
| Hosking, D | 1 |
| Yates, AJ | 1 |
| Christiansen, C | 1 |
1 trial available for alendronate and Leanness
| Article | Year |
|---|---|
Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.
Topics: Alendronate; Body Mass Index; Bone Density; Collagen; Collagen Type I; Female; Humans; Middle Aged; | 1999 |